The Mechanism of Antimicrobial Peptide MPX against Enterohemorrhagic Escherichia coli in Vitro
Escherichia coli is a facultative anaerobic bacteria that exists in the gastrointestinal tract of humans and animals. It can cause diarrhea, enteritis, destruction of the host's intestinal barrier, and intestinal microecological disturbances. In recent years, due to the abuse of traditional antibiotics, a variety of drug-resistant strains and super bacteria have emerged in an endless stream. Therefore, there is an urgent need to find new alternatives to antibiotics. Antimicrobial peptides are a type of small peptides produced when organisms resist the invasion of foreign microorganisms. They are considered to be the best alternative to antibiotics which has become a research hotspot in recent years. The antimicrobial peptide MPX is extracted from wasp venom and has a good bactericidal effect on many bacteria. To explore the effect of MPX against E. coli. The function of MPX against E. coli was detected by MIC, plate count, propidium iodide, NPN and DiSC3(5) permeability testing, immunofluorescence microscope observation, and the impact of MPX stability by temperature, pH, ion. In this study, the results found that MPX has good antibacterial activity against E. coli, and the minimum inhibitory concentration (MIC) was 31.25 ug/mL. MPX bactericidal kinetics study found that MPX had good bactericidal activity within 6 hours. Bacterial permeability studies have shown that MPX could increase the permeability of bacteria, leading to an increase in the protein content of the bacterial supernatant. In addition, NPN, PI and DiSC3(5) results showed that the fluorescence value was positively correlated with MPX. The stability test of MPX found that salt ions, temperature, pH, etc. have a slight influence on its effect. In addition, scanning electron microscopy results showed that the bacteria became smaller and the contents leaked after the action of MPX. The above results showed that MPX has a good bactericidal activity in vitro, laying the foundation for the development of new drugs for the treatment of bacterial infections.
2. Andrejko M, Mak P, Sieminska-Kuczer A, et al. (2021). A comparison of the production of antimicrobial peptides and proteins by Galleria mellonella larvae in response to infection with two Pseudomonas aeruginosa strains differing in the profile of secreted proteases. J Insect Physiol. 104239, doi:10.1016/j.jinsphys.2021.104239.
3. Fayemi O E, Akanni G B, Elegbeleye J A, Aboaba O O, Njage P M. (2021). Prevalence, characterization and antibiotic resistance of Shiga toxigenic Escherichia coli serogroups isolated from fresh beef and locally processed ready-to-eat meat products in Lagos, Nigeria. Int J Food Microbiol. 347, 109191, doi:10.1016/j.ijfoodmicro.2021.109191.
4. Fleckenstein J M, Hardwidge P R, Munson G P, Rasko D A, Sommerfelt H, Steinsland H. (2010). Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 12, 89-98, doi:10.1016/j.micinf.2009.10.002.
5. Ghosh C, Manjunath G B, Konai M M, et al. (2016). Aryl-alkyl-lysines: Membrane-Active Small Molecules Active against Murine Model of Burn Infection. ACS Infect Dis. 2, 111-22, doi:10.1021/acsinfecdis.5b00092.
6. Grasteau A, Tremblay Y D, Labrie J, Jacques M. (2011). Novel genes associated with biofilm formation of Actinobacillus pleuropneumoniae. Vet Microbiol. 153, 134-43, doi:10.1016/j.vetmic.2011.03.029.
7. Henriksen J R, Etzerodt T, Gjetting T, Andresen T L. (2014). Side chain hydrophobicity modulates therapeutic activity and membrane selectivity of antimicrobial peptide mastoparan-X. PLoS One. 9, e91007, doi:10.1371/journal.pone.0091007.
8. Konai M M, Ghosh C, Yarlagadda V, Samaddar S, Haldar J. (2014). Membrane active phenylalanine conjugated lipophilic norspermidine derivatives with selective antibacterial activity. J Med Chem. 57, 9409-23, doi:10.1021/jm5013566.
9. Liu Y, Shi J, Tong Z, Jia Y, Yang K, Wang Z. (2020). Potent Broad-Spectrum Antibacterial Activity of Amphiphilic Peptides against Multidrug-Resistant Bacteria. Microorganisms. 8, doi:10.3390/microorganisms8091398.
10. Luu T, Li W, O'Brien-Simpson N M, Hong Y. (2021). Recent Applications of Aggregation Induced Emission Probes for Antimicrobial Peptide Studies. Chem Asian J. doi:10.1002/asia.202100102.
11. Madhavan T P, Sakellaris H. (2015). Colonization factors of enterotoxigenic Escherichia coli. Adv Appl Microbiol. 90, 155-97, doi:10.1016/bs.aambs.2014.09.003.
12. Mishra B, Lakshmaiah N J, Lushnikova T, Zhang Y, Golla R M, Zarena D, Wang G. (2020). Sequence Permutation Generates Peptides with Different Antimicrobial and Antibiofilm Activities. Pharmaceuticals (Basel). 13, doi:10.3390/ph13100271.
13. Morroni G, Sante L D, Simonetti O, et al. (2021). Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates. Future Microbiol. 16, 221-227, doi:10.2217/fmb-2020-0204.
14. Sarjana S K, Sarower B G, Hassan H S, et al. (2021). Genotypic and phenotypic profiles of antibiotic-resistant bacteria isolated from hospitalized patients in Bangladesh. Trop Med Int Health. doi:10.1111/tmi.13584.
15. Shin H, Kim Y, Han D, Hur H G. (2021). Emergence of High Level Carbapenem and Extensively Drug Resistant Escherichia coli ST746 Producing NDM-5 in Influent of Wastewater Treatment Plant, Seoul, South Korea. Front Microbiol. 12, 645411, doi:10.3389/fmicb.2021.645411.
16. Song X, Yang Y, Li J, et al. (2021). Tannins extract from Galla Chinensis can protect mice from infection by Enterotoxigenic Escherichia coli O101. BMC Complement Med Ther. 21, 84, doi:10.1186/s12906-021-03261-x.
17. Uppu D S, Akkapeddi P, Manjunath G B, Yarlagadda V, Hoque J, Haldar J. (2013). Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agents. Chem Commun (Camb). 49, 9389-91, doi:10.1039/c3cc43751e.
18. Van Boeckel T P, Pires J, Silvester R, et al. (2019). Global trends in antimicrobial resistance in animals in low- and middle-income countries. Science. 365, doi:10.1126/science.aaw1944.
19. Vergis J, Malik S S, Pathak R, et al. (2020). Exploiting Lactoferricin (17-30) as a Potential Antimicrobial and Antibiofilm Candidate Against Multi-Drug-Resistant Enteroaggregative Escherichia coli. Front Microbiol. 11, 575917, doi:10.3389/fmicb.2020.575917.
20. Wang L, Zhao X, Zhu C, et al. (2017). Thymol kills bacteria, reduces biofilm formation, and protects mice against a fatal infection of Actinobacillus pleuropneumoniae strain L20. Vet Microbiol. 203, 202-210, doi:10.1016/j.vetmic.2017.02.021.
21. Wang L, Zhao X, Zhu C, et al. (2020). The antimicrobial peptide MPX kills Actinobacillus pleuropneumoniae and reduces its pathogenicity in mice. Vet Microbiol. 243, 108634, doi:10.1016/j.vetmic.2020.108634.
This work is licensed under a Creative Commons Attribution 4.0 International License.